Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02160379
Other study ID # 219/09
Secondary ID
Status Completed
Phase N/A
First received June 4, 2014
Last updated June 6, 2014
Start date January 2011
Est. completion date March 2012

Study information

Verified date June 2014
Source University of Lausanne
Contact n/a
Is FDA regulated No
Health authority Switzerland: University of Lausanne
Study type Observational

Clinical Trial Summary

This is a cross-sectional study enrolling

- 11 weight-stable, formerly obese female patients 1-5 years after Roux-en-Y gastric Bypass (RYGB)

- 11 age- and weight-matched female subjects

- 10 normal weight (Body Mass Index 19-25 kg/m2) subjects The following measurements will be performed in each participants in basal conditions (after an overnight fast) and after ingestion of a standard meal

- electroencephalographic recordings of visually evoked potential after presentation of food- or non-food pictures

- plasma concentration of metabolites (glucose, fatty acids), glucoregulatory hormones (insulin, glucagon), gastro-intestinal hormones (Gastric Inhibitory Polypeptide (GIP), Glucagon-like Peptide-1 (GLP1), ghrelin,Cholecystokinin (CCK), and bile acids Aims of this observational study are

- to evaluate the effects of RYGB on brain perception of food related visual stimulation

- to search for relationships between RYGB effects on brain responses and gastro-intestinal hormone secretion


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date March 2012
Est. primary completion date March 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- good apparent health

- gender: female

- age 18-50

- non-smoker

Exclusion Criteria:

- diabetes or antidiabetic medication

- consumption of more than 50g alcohol per week

- vegetarian or any special diet

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Other:
standard test meal


Locations

Country Name City State
Switzerland CHUV-clinical research center Lausanne VD

Sponsors (1)

Lead Sponsor Collaborator
University of Lausanne

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes of visually-evoked EEG potentials after ingestion of a meal Recording and analysis of visual evoked potentials (VEPs) while patients categorize photographs of foods and non-food kitchen utensils basal, 120 min postprandial and 240 postprandial No
Secondary changes in plasma triglyceride concentration after ingestion of a meal Measurement of triglyceride concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal) basal, 90 min postprandial and 180 postprandial No
Secondary Changes in plasma glucoincretins (GLP1 and GIP) concentrations after ingestion of a meal Measurement of GLP1 and GIP concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal) basal, 90 min postprandial and 180 postprandial No
Secondary Changes in plasma cholecystokinin concentrations after ingestion of a meal Measurement of cholecystokinin concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal) basal, 90 min postprandial and 180 postprandial No
Secondary Changes in plasma bile acids concentrations after ingestion of a meal Measurement of bile acids concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal) basal, 90 min postprandial and 180 postprandial No
Secondary changes in plasma glucoregulatory status after ingestion of a meal Measurement of glucose, insulin, glucagon and non-esterified fatty acid concentrations at 30-60 min intervals in basal conditions (after an overnight fast) and over 6 hours after ingestion of a standard meal) basal, 90 min postprandial and 180 postprandial No
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2